# LRRTM3

## Overview
LRRTM3, or Leucine Rich Repeat Transmembrane Neuronal 3, is a gene that encodes a protein belonging to the leucine-rich repeat transmembrane neuronal protein family. This protein is primarily involved in synaptic adhesion and signaling within the central nervous system, playing a critical role in the development and maintenance of synaptic connections. Structurally, the LRRTM3 protein is characterized by its leucine-rich repeat domains, a transmembrane domain, and a PDZ domain binding motif, which facilitate its interactions with other synaptic proteins (Uvarov2014Origin; Yamagata2018Structural). Notably, LRRTM3 interacts with presynaptic neurexins and heparan sulfate proteoglycans, contributing to synaptogenesis and synaptic plasticity (Roppongi2020LRRTMs). The gene has also been implicated in the pathogenesis of Alzheimer's disease, as it influences the metabolism of amyloid precursor protein and beta-secretase 1, key components in amyloid-beta production (Lincoln2013LRRTM3). Understanding the function and interactions of LRRTM3 is crucial for elucidating its role in neural communication and its potential impact on neurodegenerative diseases.

## Structure
LRRTM3 is a postsynaptic adhesion protein characterized by its molecular structure, which includes ten N-terminal leucine-rich repeat (LRR) domains, a single-pass transmembrane domain, and a C-terminal cytoplasmic tail with a PDZ domain binding motif (Uvarov2014Origin). The LRR domains contribute to the protein's ability to engage in protein-protein interactions, forming a horseshoe-shaped structure typical of the LRR superfamily. This structure is crucial for its role in synaptic development and function.

LRRTM3 is nested within the CTNNA3 gene in most jawed vertebrates, indicating a conserved genomic arrangement (Uvarov2014Origin). The protein's interaction with presynaptic neurexins and heparan sulfate proteoglycans (HSPGs) suggests an evolutionary adaptation for synaptic adhesion, although its binding to neurexins is weaker compared to other LRRTM family members (Yamagata2018Structural). Specific amino acid substitutions in LRRTM3, such as the replacement of Glu348 with Val and Phe357 with Tyr, likely affect its binding affinity and interaction with neurexins (Yamagata2018Structural).

The protein's structure and interactions are influenced by post-translational modifications and potential splice variants, which may alter its activity and localization within synaptic environments. However, detailed structural studies specifically focusing on LRRTM3 are limited compared to other LRRTM proteins.

## Function
LRRTM3 is a member of the leucine-rich repeat transmembrane neuronal protein family, which plays a crucial role in synapse development and function in the central nervous system. It is primarily involved in synaptic adhesion and signaling, contributing to the formation and maintenance of synaptic connections. LRRTM3 interacts with neurexins, a family of presynaptic cell adhesion molecules, through heparan sulfate modifications, which are essential for its synaptogenic activity (Roppongi2020LRRTMs). This interaction is critical for presynaptic differentiation and the organization of excitatory synapses (Roppongi2020LRRTMs).

LRRTM3 is predominantly expressed in the brain, particularly in regions such as the hippocampus and cerebellum, where it influences neuronal communication and plasticity (Smith2011Alpha; Sousa2010Polymorphisms). It is also involved in the processing of amyloid precursor protein (APP) and BACE1, which are key components in the pathogenesis of Alzheimer's disease. LRRTM3 co-localizes with APP and BACE1 in early endosomes, suggesting a role in modulating APP metabolism and amyloid-beta production (Lincoln2013LRRTM3). These functions highlight its importance in maintaining synaptic integrity and facilitating proper neural communication.

## Clinical Significance
The LRRTM3 gene is implicated in late-onset Alzheimer's disease (LOAD) due to its role in amyloid-beta metabolism. Variants within LRRTM3 have been associated with LOAD risk, particularly through their interaction with amyloid precursor protein (APP) and beta-secretase 1 (BACE1), which are crucial in the production of amyloid-beta peptides, a hallmark of Alzheimer's pathology (Lincoln2013LRRTM3). Knockdown studies in vitro have shown that reducing LRRTM3 expression leads to decreased levels of amyloid-beta peptides, suggesting that alterations in LRRTM3 expression can influence Alzheimer's disease progression (Lincoln2013LRRTM3).

Genetic studies have identified single nucleotide polymorphisms (SNPs) within LRRTM3 that form multilocus genotypes associated with LOAD, although individual SNPs did not show significant associations after correction for multiple testing (Lincoln2013LRRTM3). The gene's expression levels correlate with those of BACE1 and APP in human brains, indicating complex interactions that may influence Alzheimer's disease risk (Lincoln2013LRRTM3). Additionally, a nominal association of the SNP rs1925617 in LRRTM3 with LOAD suggests a potential protective effect against the disease (Edwards2009An). These findings highlight the clinical significance of LRRTM3 in Alzheimer's disease, warranting further research into its genetic and functional roles.

## Interactions
LRRTM3 interacts with neurexins, particularly neurexin 1β, to play a crucial role in synapse development and function. These interactions are dependent on the heparan sulfate (HS) modification of neurexins, which is essential for binding and synaptogenesis. LRRTM3 can bind to neurexin variants, with the interaction being abolished by heparinase treatment, indicating the importance of HS modification (Roppongi2020LRRTMs). 

LRRTM3 also interacts with heparan sulfate proteoglycans (HSPGs) and neurexins lacking an insert at splice site 4 (S4) in vitro. The synaptogenesis mediated by LRRTM3 is significantly reduced by the knockdown of neurexins 1-3, highlighting neurexins as primary presynaptic ligands for LRRTM3 (Yamagata2018Structural). 

In addition to neurexins, LRRTM3 is involved in interactions with other receptor families. The Lrrtm subfamily, which includes LRRTM3, can form both homo- and heterotypic interactions, suggesting a role in diverse receptor interactions (Söllner2009A). These interactions are crucial for synaptic specificity and plasticity, contributing to the organization and maintenance of synapses in the nervous system.


## References


[1. (Smith2011Alpha) James D. Smith, Maria H. Meehan, John Crean, and Amanda McCann. Alpha t-catenin (ctnna3): a gene in the hand is worth two in the nest. Cellular and Molecular Life Sciences, 68(15):2493–2498, May 2011. URL: http://dx.doi.org/10.1007/s00018-011-0728-0, doi:10.1007/s00018-011-0728-0. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-011-0728-0)

[2. (Söllner2009A) Christian Söllner and Gavin J Wright. A cell surface interaction network of neural leucine-rich repeat receptors. Genome Biology, 10(9):R99, 2009. URL: http://dx.doi.org/10.1186/gb-2009-10-9-r99, doi:10.1186/gb-2009-10-9-r99. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2009-10-9-r99)

[3. (Roppongi2020LRRTMs) Reiko T. Roppongi, Shreya H. Dhume, Nirmala Padmanabhan, Prabhisha Silwal, Nazmeena Zahra, Benyamin Karimi, Claire Bomkamp, Chetan S. Patil, Kevin Champagne-Jorgensen, Rebecca E. Twilley, Peng Zhang, Michael F. Jackson, and Tabrez J. Siddiqui. Lrrtms organize synapses through differential engagement of neurexin and ptpσ. Neuron, 106(1):108-125.e12, April 2020. URL: http://dx.doi.org/10.1016/j.neuron.2020.01.003, doi:10.1016/j.neuron.2020.01.003. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2020.01.003)

[4. (Uvarov2014Origin) Pavel Uvarov, Tommi Kajander, and Matti S. Airaksinen. Origin and loss of nested lrrtm/α-catenin genes during vertebrate evolution. PLoS ONE, 9(2):e89910, February 2014. URL: http://dx.doi.org/10.1371/journal.pone.0089910, doi:10.1371/journal.pone.0089910. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0089910)

[5. (Yamagata2018Structural) Atsushi Yamagata, Sakurako Goto-Ito, Yusuke Sato, Tomoko Shiroshima, Asami Maeda, Masahiko Watanabe, Takashi Saitoh, Katsumi Maenaka, Tohru Terada, Tomoyuki Yoshida, Takeshi Uemura, and Shuya Fukai. Structural insights into modulation and selectivity of transsynaptic neurexin–lrrtm interaction. Nature Communications, September 2018. URL: http://dx.doi.org/10.1038/s41467-018-06333-8, doi:10.1038/s41467-018-06333-8. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-06333-8)

[6. (Edwards2009An) Todd L. Edwards, Margaret Pericak‐Vance, Johnny R. Gilbert, Jonathan L. Haines, Eden R. Martin, and Marylyn D. Ritchie. An association analysis of alzheimer disease candidate genes detects an ancestral risk haplotype clade in ace and putative multilocus association between ace, a2m, and lrrtm3. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B(5):721–735, June 2009. URL: http://dx.doi.org/10.1002/ajmg.b.30899, doi:10.1002/ajmg.b.30899. This article has 29 citations.](https://doi.org/10.1002/ajmg.b.30899)

[7. (Sousa2010Polymorphisms) Inês Sousa, Taane G Clark, Richard Holt, Alistair T Pagnamenta, Erik J Mulder, Ruud B Minderaa, Anthony J Bailey, Agatino Battaglia, Sabine M Klauck, Fritz Poustka, and Anthony P Monaco. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of european ancestry. Molecular Autism, March 2010. URL: http://dx.doi.org/10.1186/2040-2392-1-7, doi:10.1186/2040-2392-1-7. This article has 50 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/2040-2392-1-7)

[8. (Lincoln2013LRRTM3) Sarah Lincoln, Mariet Allen, Claire L. Cox, Louise P. Walker, Kimberly Malphrus, Yushi Qiu, Thuy Nguyen, Christopher Rowley, Naomi Kouri, Julia Crook, V. Shane Pankratz, Samuel Younkin, Linda Younkin, Minerva Carrasquillo, Fanggeng Zou, Samer O. Abdul-Hay, Wolfdieter Springer, Sigrid B. Sando, Jan O. Aasly, Maria Barcikowska, Zbigniew K. Wszolek, Jada M. Lewis, Dennis Dickson, Neill R. Graff-Radford, Ronald C. Petersen, Elizabeth Eckman, Steven G. Younkin, and Nilüfer Ertekin-Taner. Lrrtm3 interacts with app and bace1 and has variants associating with late-onset alzheimer’s disease (load). PLoS ONE, 8(6):e64164, June 2013. URL: http://dx.doi.org/10.1371/journal.pone.0064164, doi:10.1371/journal.pone.0064164. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0064164)